Literature DB >> 8554861

A pilot evaluation of conductive education-based intervention for children with cerebral palsy: the Tongala project.

G J Coleman1, J A King, D S Reddihough.   

Abstract

OBJECTIVE: To perform an objective evaluation of a programme based on conductive education (CE).
METHODOLOGY: Two groups of children with cerebral palsy were studied over 6 months. Eleven children participated in a CE-based programme and nine children received traditional early intervention programmes. Videotapes of the children performing items from the Vulpe Assessment Battery (VAB) were scored by assessors blind to the treatment group. The questionnaire on resources and stress (QRS-F) was administered to the primary caregiver.
RESULTS: Few statistically significant results were obtained. There was a trend for the conductive education-based group to make slightly greater gains. The videotaped measures yielded high Chronbach coefficients and high interrater correlation coefficients suggesting that this is a useful method to evaluate progress.
CONCLUSIONS: The study was limited by small sample size, the nature of the control group and the lack of random assignment to CE and control groups. It did provide a basis for the development of further research in the area.

Entities:  

Mesh:

Year:  1995        PMID: 8554861     DOI: 10.1111/j.1440-1754.1995.tb00849.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  2 in total

1.  [Botulinum toxin A in the treatment of infantile cerebral palsy. Taking into account multilevel, integrated treatment].

Authors:  G Molenaers; K Desloovere; J De Cat
Journal:  Orthopade       Date:  2004-10       Impact factor: 1.087

Review 2.  Intensive training of motor function and functional skills among young children with cerebral palsy: a systematic review and meta-analysis.

Authors:  Hilde Tinderholt Myrhaug; Sigrid Østensjø; Lillebeth Larun; Jan Odgaard-Jensen; Reidun Jahnsen
Journal:  BMC Pediatr       Date:  2014-12-05       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.